Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.30 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | CDK9 | P50750 | 1/20 | 0.30 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.30 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.30 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.30 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.30 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21881749 | 0.92 | KMT2A (0.42) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL12166316 | 0.91 | KMT2A (0.40) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL12166311 | 0.89 | SMN1; SMN2 (0.38) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL22473031 | 0.84 | MEN1 (0.47) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL19293872 | 0.84 | MEN1 (0.47) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL30865507 | 0.84 | PDK2 (0.36) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL12166448 | 0.84 | KCNQ2 (0.33) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL12166302 | 0.83 | MEN1 (0.38) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL12166317 | 0.83 | MEN1 (0.44) | MEN1MAPTKMT2AKDM4ELMNA | |
| SCHEMBL22869120 | 0.82 | MEN1 (0.42) | MEN1MAPTKMT2AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795186-B2 | Organic electronic device comprising an organic semiconductor layer and a device | NOVALED GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| US-11795186-B2 | Organic electronic device comprising an organic semiconductor layer and a device | NOVALED GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| US-20200161559-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | NOVALED GMBH (DE) | 2020-05-21 | — | — | US | disclosed |
| US-20200095269-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device | NOVALED GMBH (DE) | 2020-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200095269-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device | C1S, C1R, CCNA1 | MEN1 762/4885MAPT 4555/4885KMT2A 3297/4885 |
| US-11795186-B2 | Organic electronic device comprising an organic semiconductor layer and a device | C1S, C1R, CCNA1 | MEN1 762/4885MAPT 4555/4885KMT2A 3297/4885 |
| US-20200161559-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | C1S, YAP1, ESR1 | MEN1 715/4885MAPT 4392/4885KMT2A 2561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.